Damon DeSantis - 24 Mar 2026 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Reporting relationship: Director
Issuer ticker: INBP
Reported as of: 24 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 25 Mar 2026, 15:39:16 UTC
Prior SEC filing: 03 Mar 2026
Next SEC filing: 17 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Damon DeSantis

Filing notes and source

Key filing fact

Damon DeSantis filed Form 4 for INTEGRATED BIOPHARMA INC (INBP) on 25 Mar 2026.

Key facts

This page summarizes Damon DeSantis's Form 4 filing for INTEGRATED BIOPHARMA INC (INBP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 25 Mar 2026, 15:39.

Change

Previous filing in this sequence was filed on 03 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001889279 Primary reporting owner

DeSantis Damon

Relationship: Director
Address: 109 SE 5TH AVENUE, SECOND FLOOR, DELRAY BEACH
Signature: /s/ Damon DeSantis
Signature date: 25 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBP transaction

Common Stock

Gift

Transaction value
Shares: +1,356,293
Change %
Price: $0.000000^*
Shares after: 1,356,293
Date: 24 Mar 2026
Ownership: By CDDS 2.0, LLC
Footnotes: F1

INBP transaction

Common Stock

Gift

Transaction value
Shares: +7,392
Change %: +0.55%
Price: $0.000000^*
Shares after: 1,363,685
Date: 24 Mar 2026
Ownership: By CDDS 2.0, LLC
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents 1,356,293 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.

Footnote F2

Represents 7,392 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by the Reporting Person.